Sort
30,917 grants matching “tumor microenvironment”
Reprogramming Tumor Microenvironment by Nanoparticle
$338,550Priyabrata Mukherjee · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2020 · CA
Reprogramming Tumor Microenvironment by Nanoparticle
$338,550Priyabrata Mukherjee · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2018 · CA
ERK3 Kinase Signaling in Lung Cancer
$338,550Weiwen Long · Wright State University · R01 · FY2018 · CA
Reprogramming Tumor Microenvironment by Nanoparticle
$338,550Priyabrata Mukherjee · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2017 · CA
ERK3 Kinase Signaling in Lung Cancer
$338,550Weiwen Long · Wright State University · R01 · FY2017 · CA
CANCAN ? CORNELL
$338,539Marcus Dasilva Goncalves · Weill Medical Coll Of Cornell Univ · OT2 · FY2022 · CA
Project 2: Measuring and modeling the tumor and immune microenvironment before and during therapy and at the time of drug resistance
$338,537Arlene H Sharpe · Harvard Medical School · U54 · FY2020 · CA
VISTA, a novel checkpoint that suppresses anti-tumor T cell responses
$338,521Li Lily Wang · Medical College Of Wisconsin · R01 · FY2015 · CA
Characterization of the interaction between inflammation and cancer progression
$338,430Robert Wiltrout · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Mechanisms of Leukocyte Migration Following Cytokine Administration to Mice
$338,430Robert Wiltrout · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Obesity, inflammation and breast cancer
$338,379Weizhou Zhang · University Of Florida · R01 · FY2019 · CA
SEQUENCE-SPECIFIC CHROMATIN MODIFIERS; NOVEL PROTEIN THERAPEUTICS FOR B CELL LYMPHOMA
$338,378Jacqueline E. Payton · Washington University · R01 · FY2019 · CA
IRAK4 As a Novel Immunotherapeutic Target in Pancreatic Ductal Adenocarcinoma
$338,378Kian H Lim · Washington University · R37 · FY2019 · CA
NOVEL SMALL MOLECULE INHIBITION OF DDR2 TO PREVENT BREAST CANCER METASTASIS
$338,378Gregory Longmore · Washington University · R01 · FY2019 · CA
COMBINED TUMOR AND STROMAL TARGETING TO IMPROVE PANCREATIC CANCER RESPONSE TO IMMUNOTHERAPY
$338,378David G Denardo · Washington University · R01 · FY2019 · CA
Project 2: Contribution of the Stromal Microenvironment to Early Dissemination
$338,377Mayumi Ito · New York University School Of Medicine · U54 · FY2024 · CA
Role of Hypoxia-Induced miR-210 in Tumor Metabolism
$338,341Mircea Ivan · Indiana University Indianapolis · R01 · FY2015 · CA
Regulatory Immune Cell Networks in Cancer
$338,327Thorsten Roman Mempel · Massachusetts General Hospital · R01 · FY2014 · CA
Project 7 - Metformin
$338,318Ernst Lengyel · Mayo Clinic Rochester · P50 · FY2016 · CA
Anti-Tumor immunity in myeloma
$338,309Madhav V Dhodapkar · Rockefeller University · R01 · FY2006 · CA
Project 2: Determinants of Response and Resistance to DNA-Damaging Radiation Plus Immunotherapy Combinations in Triple Negative Breast Cancer
$338,306Gaorav P. Gupta · Univ Of North Carolina Chapel Hill · P50 · FY2024 · CA
Exploiting Caveolae-Dependent Albumin Endocytosis to Optimize Therapy in Pancreatic Cancer
$338,263Terence Marques Williams · Ohio State University · R01 · FY2020 · CA
Inflammatory microenvironment in brain metastasis
$338,252Devon A. Lawson · University Of California-Irvine · R01 · FY2022 · CA
Myeloid Suppressor Cell-Mediated Immune Suppression of Tumor Specific T Cells
$338,202Shu-Hsia Chen · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · CA
Project 1: Overcoming Tumor-Induced Immune Suppression to Improve Responses to Immunotherapy
$338,182David G Denardo · Washington University · P50 · FY2017 · CA